These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22617129)

  • 1. Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.
    Felix AS; Edwards RP; Stone RA; Chivukula M; Parwani AV; Bowser R; Linkov F; Weissfeld JL
    Br J Cancer; 2012 Jun; 106(12):2004-9. PubMed ID: 22617129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
    Ru GQ; Zhao ZS; Tang QL; Xu WJ
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer.
    Zhang W; Chu YQ; Ye ZY; Zhao ZS; Tao HQ
    Anat Rec (Hoboken); 2009 Aug; 292(8):1114-21. PubMed ID: 19533745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients.
    Masuya D; Huang C; Liu D; Nakashima T; Kameyama K; Haba R; Ueno M; Yokomise H
    Br J Cancer; 2004 Apr; 90(8):1555-62. PubMed ID: 15083185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of angiogenic factors in sclerosing stromal tumours of the ovary.
    Hirakawa T; Kawano Y; Mizoguchi C; Nasu K; Narahara H
    J Obstet Gynaecol; 2018 Jul; 38(5):682-685. PubMed ID: 29433373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer.
    Yoshida S; Harada T; Iwabe T; Taniguchi F; Fujii A; Sakamoto Y; Yamauchi N; Shiota G; Terakawa N
    J Clin Endocrinol Metab; 2002 May; 87(5):2376-83. PubMed ID: 11994390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
    Banas T; Pitynski K; Okon K; Winiarska A
    BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
    Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
    BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma.
    Wagatsuma S; Konno R; Sato S; Yajima A
    Cancer; 1998 Feb; 82(3):520-30. PubMed ID: 9452270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma.
    Bishop EA; Lengyel ER; Yamada SD; Montag A; Temkin SM
    Gynecol Oncol; 2011 Apr; 121(1):218-23. PubMed ID: 21168200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma.
    Dobrzycka B; Mackowiak-Matejczyk B; Kinalski M; Terlikowski SJ
    Gynecol Oncol; 2013 Mar; 128(3):454-60. PubMed ID: 23206584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
    Felix AS; Stone RA; Bowser R; Chivukula M; Edwards RP; Weissfeld JL; Linkov F
    Int J Gynecol Cancer; 2011 Jul; 21(5):877-84. PubMed ID: 21666484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between microsatellite instability and hepatocyte growth factor expression and their prognostic significance in colorectal cancer].
    Yang G; Zheng HX; Wu LN; Wan HL; Li N; Yang GC; Liang JF
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):283-8. PubMed ID: 27087375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
    Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
    Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.
    Qiu SQ; van Rooijen J; Nienhuis HH; van der Vegt B; Timmer-Bosscha H; van Leeuwen-Stok E; Walenkamp AME; van Deurzen CHM; de Bock GH; de Vries EGE; Schröder CP
    Breast Cancer Res; 2020 Mar; 22(1):30. PubMed ID: 32188473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
    Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
    Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival.
    Smith K; Fox SB; Whitehouse R; Taylor M; Greenall M; Clarke J; Harris AL
    Ann Oncol; 1999 Jun; 10(6):707-13. PubMed ID: 10442194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.